EGFR and neoplasm: Cox-regression analyses was undertaken to determine the prognostic value of Cav-1 tumour levels as a covariate with IDH1 status (wild type or mutation), MGMT promoter methylation, EGFR-vIII amplification, PTEN and TP53 mutation (Table 1A).